Skip to content

Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?

Evaluation of COVID-19 Incidence in Patients With Preeclampsia During Pandemic

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04443140
Enrollment
131
Registered
2020-06-23
Start date
2020-03-15
Completion date
2020-07-10
Last updated
2020-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19, Preeclampsia, Pregnancy Related

Keywords

covıd-19, pregnancy, preeclampsia, preeclampsia-like syndrome

Brief summary

By applying polymerase chain reaction (PCR) test for Covid-19 to preeclampsia patients who applied to our hospital during the Covid-19 pandemic period, we investigated the frequency of Covid-19 related preeclampsia-like syndrome in this patient group.

Detailed description

The investigators studied the frequency of Covid-19 related preeclampsia-like syndrome by PCR test and lung ultrasound for Covid-19 to preeclampsia patients presenting to the instutution during the Covid-19 pandemic period. The first consecutive 100 preeclampsia patients presented to our hospital during the pandemic will be involved in our study. The primary outcome measure is to detect Covid-19 positivity among the preeclamptic pregnant women..

Interventions

DIAGNOSTIC_TESTPCR, lung ultrasound

PCR for Covid-19

Sponsors

Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* First consecutive 100 pregnant women presenting with preeclamptic symptoms and signs between March 15, 2020 and June 1, 2020.

Exclusion criteria

* The pregnancies with known diagnosis of preeclampsia before Covid-19 pandemic * Preeclamptic patient without a Covid-19 PCR test result * Pregnant women who does not want to participate in study or does not want their personal informations to be shared * Pregnant women less than 18 years old and more than 40 years old are excluded

Design outcomes

Primary

MeasureTime frameDescription
PCR positivity3 monthsTo detect Covid-19 PCR test positivity among preeclamptic pregnant women

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026